KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Co-Diagnostics (CODX) Long-Term Investments (2023 - 2025)

Historic Long-Term Investments for Co-Diagnostics (CODX) over the last 3 years, with Q3 2025 value amounting to $659903.0.

  • Co-Diagnostics' Long-Term Investments fell 1586.7% to $659903.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $659903.0, marking a year-over-year decrease of 1586.7%. This contributed to the annual value of $731065.0 for FY2024, which is 547.17% down from last year.
  • According to the latest figures from Q3 2025, Co-Diagnostics' Long-Term Investments is $659903.0, which was down 1586.7% from $715861.0 recorded in Q2 2025.
  • In the past 5 years, Co-Diagnostics' Long-Term Investments ranged from a high of $784357.0 in Q3 2024 and a low of $627924.0 during Q2 2024
  • For the 3-year period, Co-Diagnostics' Long-Term Investments averaged around $717444.7, with its median value being $729621.0 (2025).
  • Data for Co-Diagnostics' Long-Term Investments shows a peak YoY increase of 1400.44% (in 2025) and a maximum YoY decrease of 1586.7% (in 2025) over the last 5 years.
  • Over the past 3 years, Co-Diagnostics' Long-Term Investments (Quarter) stood at $773382.0 in 2023, then dropped by 5.47% to $731065.0 in 2024, then dropped by 9.73% to $659903.0 in 2025.
  • Its Long-Term Investments was $659903.0 in Q3 2025, compared to $715861.0 in Q2 2025 and $729621.0 in Q1 2025.